United Therapeutics EVP Paul Mahon sells $4.1M in shares
Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash
Paul A. Mahon, Executive Vice President and General Counsel at United Therapeutics Corp. (NASDAQ:UTHR), sold 8,300 shares for over $4.1 million on September 17, 2026, under a pre-arranged trading plan, after exercising 8,300 stock options. The company recently settled with Liquidia Technologies, posted a Q2 revenue miss and won legal victories tied to its Tyvaso franchise.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.